MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/ijlh.14525

Медицинская библиотека · International journal of laboratory hematology · 2025

Assessing the Persistence and Relevance of Small T-LGL Clones via TRBC1 in a Flowcytometric Lymphoid Screening Tube.

Debunne Nathan, Cauwelier Barbara, Devos Helena, Snauwaert Sylvia, Emmerechts Jan

СтатьяПеревод пока не подготовлен

Аннотация

INTRODUCTION

Recently, monoclonal antibodies targeting one of the two mutually exclusive constant regions of the TCR β receptor chain (TRBC1 and TRBC2) have been proposed as a surrogate tool for assessing T-cell clonality by flowcytometry. The detection of T-cell clones is typically interpreted in the context of malignancy. However, small T-cell clones of uncertain significance (T-CUS) are frequently identified, posing diagnostic and clinical challenges. Since 2022, TRBC1 was incorporated as a marker for T-cell clonality in our flowcytometric lymphoid screening tube (LST), a tube designed to detect both B- and T-cell aberrancies in the blood of patients with clinical suspicion of hematological malignancy. The objective of the current study was to systematically evaluate the frequency and size of T-cell clones identified at initial diagnosis and to evaluate clonal evolution in follow-up samples.

METHODS

In this single-centre retrospective study (2022-2024), peripheral blood samples of 3495 unique patients were tested for T-cell clonality using TRBC1. The monotypic T-cell clones of > 50/μL were stratified into three groups: T-CUS1 (50-500 monotypic cells/μL), T-CUS2 (500-2000 monotypic cells/μL), and T-LGL (> 2000 monotypic cells/μL). Follow-up samples were obtained at least 6 months after initial testing (range: 6-30 months) and potential indicators of progression to T-CUS2 or T-LGL were evaluated.

RESULTS

The majority of T-CUS clones (22/36, 61%) were not detected (< 50 monotypic cells/μL) at follow-up, thereby demonstrating the importance of evaluation of the persistance of small T-cell clones. Fifteen percent of patients with a T-CUS1 progressed to T-CUS2, but none to T-LGL (95% CI: 0%-15%). 22% (95% CI: 3%-60%) of T-CUS2 patients evolved to T-LGL, all of which showed aberrant expression of CD57. In the patient group who showed evolution to T-CUS2 or T-LGL, significantly lower hemoglobin levels and neutrophil counts were observed at the time of T-CUS detection. Additionally, in this group, comparable increases in monotypic T-cell clones were observed over time, with a main increment of 90 monotypic cells/μL per month (95% CI: 34%-145%).

CONCLUSIONS

The low number of persistence observed in T-CUS at follow-up highlights the need for cautious interpretation of small T-cell clones (T-CUS1). Low hemoglobin and neutrophil counts at diagnosis might indicate higher risk for progression and need for closer follow-up.

Для цитирования: Debunne Nathan, Cauwelier Barbara, Devos Helena, Snauwaert Sylvia, Emmerechts Jan. Assessing the Persistence and Relevance of Small T-LGL Clones via TRBC1 in a Flowcytometric Lymphoid Screening Tube.. International journal of laboratory hematology. 2025. DOI: 10.1111/ijlh.14525.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.